Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generic drugs: the stalling game

    Consumer Reports
    |December 1, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Generic drug prices remain high due to "sweetheart deals" and extended patent protections, delaying consumer access to affordable medications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    The Safest Car Seat for Your Child.

    Consumer reports·2016
    Same journal

    An Essential Heart-Surgery Device Has a Rare But Deadly Side Effect.

    Consumer reports·2016
    Same journal

    Zero Tolerance.

    Consumer reports·2016
    Same journal

    Colon cancer runs in my family: Should I get a genetic test? I worry that'll affect my insurance.

    Consumer reports·2016
    Same journal

    How to Survive a High-Deductible Health Plan. Is your insurance giving you a bad case of sticker shock? Here are ways to ease the pain.

    Consumer reports·2016
    Same journal

    Your Health Is Priceless.

    Consumer reports·2016
    See all related articles

    Area of Science:

    • Pharmaceutical economics
    • Drug pricing policy
    • Healthcare access

    Background:

    • Generic drugs offer significant cost savings compared to brand-name drugs.
    • Timely market entry of generics is crucial for reducing healthcare expenditures.
    • The pharmaceutical industry employs various strategies to maintain market exclusivity.

    Purpose of the Study:

    • To investigate the impact of specific industry practices on generic drug availability.
    • To analyze the role of patent extensions and settlement agreements in drug pricing.
    • To understand how these practices affect consumer access to affordable medicines.

    Main Methods:

    • Analysis of patent litigation data and settlement agreements.
    • Examination of drug approval timelines and market entry dates for generics.

    Related Experiment Videos

  • Economic modeling to assess the impact of delayed generic entry on drug prices.

    • Main Results:

    • "Sweetheart deals" (pay-for-delay agreements) were found to significantly delay generic competition.
    • Patent term extensions, often granted through secondary patents, further prolonged brand-name drug monopolies.
    • These practices collectively resulted in higher drug costs for consumers and healthcare systems.

    Conclusions:

    • Anti-competitive practices, including patent manipulation and settlement agreements, hinder generic drug market entry.
    • Policy interventions are needed to curb these practices and ensure timely access to affordable generic medications.
    • Addressing these issues is vital for improving healthcare affordability and patient access to essential drugs.